Cargando…

A new second-generation supraglottic airway device (Ambu(®) AuraGain(•)) versus intubating laryngeal mask airway as conduits for blind intubation – A prospective, randomised trial

BACKGROUND AND AIMS: The Ambu(®) AuraGain(•) is a new single-use supraglottic airway device with gastric channel, designed to facilitate intubation. The study aimed to assess the success rates of proper placement and intubation using Ambu(®) AuraGain(•) compared with intubating laryngeal mask airway...

Descripción completa

Detalles Bibliográficos
Autores principales: Sudheesh, K, Chethana, GM, Chaithali, H, Nethra, SS, Devikarani, D, Shwetha, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6644201/
https://www.ncbi.nlm.nih.gov/pubmed/31391619
http://dx.doi.org/10.4103/ija.IJA_269_19
_version_ 1783437210273447936
author Sudheesh, K
Chethana, GM
Chaithali, H
Nethra, SS
Devikarani, D
Shwetha, G
author_facet Sudheesh, K
Chethana, GM
Chaithali, H
Nethra, SS
Devikarani, D
Shwetha, G
author_sort Sudheesh, K
collection PubMed
description BACKGROUND AND AIMS: The Ambu(®) AuraGain(•) is a new single-use supraglottic airway device with gastric channel, designed to facilitate intubation. The study aimed to assess the success rates of proper placement and intubation using Ambu(®) AuraGain(•) compared with intubating laryngeal mask airway (ILMA). METHODS: One hundred and twenty patients (18–60 years) were enrolled into this prospective, randomised, comparative study. After inducing general anaesthesia, appropriate size ILMA (group I)/Ambu(®) AuraGain(•) (group A) was placed as per the manufacturer's recommendations and correct placement was confirmed. Appropriate size endotracheal tube was passed through the device. The success rate of insertion and intubation, number of attempts, Cormack–Lehane grading before insertion and haemodynamics were recorded. Data were analysed using Mantel–Haenszel Chi-square test, Student's t-test and Fisher's exact test. RESULTS: Demographic and airway parameters were uniformly distributed in both the groups. The success rate for insertion was 100% in both devices. The success rate for intubation was 96.6% (58/60) in group I and 36.6% in group A (P < 0.001). In group I, patients with mean thyromental distance >7.62 ± 0.75 cm had higher successful intubation compared with patients with mean thyromental distance <5.25 ± 0.35 cm (P = 0.014). Cormack–Lehane grading did not correlate with intubation attempts or success rate in group I (P = 0.45), whereas in group A the rate of successful blind intubation with Cormack–Lehane grade 1 was 50% (19/38). CONCLUSION: Both devices have 100% insertion success, though Ambu(®) AuraGain(•) has lower success rate for facilitating intubation compared with ILMA.
format Online
Article
Text
id pubmed-6644201
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-66442012019-08-07 A new second-generation supraglottic airway device (Ambu(®) AuraGain(•)) versus intubating laryngeal mask airway as conduits for blind intubation – A prospective, randomised trial Sudheesh, K Chethana, GM Chaithali, H Nethra, SS Devikarani, D Shwetha, G Indian J Anaesth Original Article BACKGROUND AND AIMS: The Ambu(®) AuraGain(•) is a new single-use supraglottic airway device with gastric channel, designed to facilitate intubation. The study aimed to assess the success rates of proper placement and intubation using Ambu(®) AuraGain(•) compared with intubating laryngeal mask airway (ILMA). METHODS: One hundred and twenty patients (18–60 years) were enrolled into this prospective, randomised, comparative study. After inducing general anaesthesia, appropriate size ILMA (group I)/Ambu(®) AuraGain(•) (group A) was placed as per the manufacturer's recommendations and correct placement was confirmed. Appropriate size endotracheal tube was passed through the device. The success rate of insertion and intubation, number of attempts, Cormack–Lehane grading before insertion and haemodynamics were recorded. Data were analysed using Mantel–Haenszel Chi-square test, Student's t-test and Fisher's exact test. RESULTS: Demographic and airway parameters were uniformly distributed in both the groups. The success rate for insertion was 100% in both devices. The success rate for intubation was 96.6% (58/60) in group I and 36.6% in group A (P < 0.001). In group I, patients with mean thyromental distance >7.62 ± 0.75 cm had higher successful intubation compared with patients with mean thyromental distance <5.25 ± 0.35 cm (P = 0.014). Cormack–Lehane grading did not correlate with intubation attempts or success rate in group I (P = 0.45), whereas in group A the rate of successful blind intubation with Cormack–Lehane grade 1 was 50% (19/38). CONCLUSION: Both devices have 100% insertion success, though Ambu(®) AuraGain(•) has lower success rate for facilitating intubation compared with ILMA. Wolters Kluwer - Medknow 2019-07 /pmc/articles/PMC6644201/ /pubmed/31391619 http://dx.doi.org/10.4103/ija.IJA_269_19 Text en Copyright: © 2019 Indian Journal of Anaesthesia http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Sudheesh, K
Chethana, GM
Chaithali, H
Nethra, SS
Devikarani, D
Shwetha, G
A new second-generation supraglottic airway device (Ambu(®) AuraGain(•)) versus intubating laryngeal mask airway as conduits for blind intubation – A prospective, randomised trial
title A new second-generation supraglottic airway device (Ambu(®) AuraGain(•)) versus intubating laryngeal mask airway as conduits for blind intubation – A prospective, randomised trial
title_full A new second-generation supraglottic airway device (Ambu(®) AuraGain(•)) versus intubating laryngeal mask airway as conduits for blind intubation – A prospective, randomised trial
title_fullStr A new second-generation supraglottic airway device (Ambu(®) AuraGain(•)) versus intubating laryngeal mask airway as conduits for blind intubation – A prospective, randomised trial
title_full_unstemmed A new second-generation supraglottic airway device (Ambu(®) AuraGain(•)) versus intubating laryngeal mask airway as conduits for blind intubation – A prospective, randomised trial
title_short A new second-generation supraglottic airway device (Ambu(®) AuraGain(•)) versus intubating laryngeal mask airway as conduits for blind intubation – A prospective, randomised trial
title_sort new second-generation supraglottic airway device (ambu(®) auragain(•)) versus intubating laryngeal mask airway as conduits for blind intubation – a prospective, randomised trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6644201/
https://www.ncbi.nlm.nih.gov/pubmed/31391619
http://dx.doi.org/10.4103/ija.IJA_269_19
work_keys_str_mv AT sudheeshk anewsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT chethanagm anewsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT chaithalih anewsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT nethrass anewsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT devikaranid anewsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT shwethag anewsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT sudheeshk newsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT chethanagm newsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT chaithalih newsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT nethrass newsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT devikaranid newsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT shwethag newsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial